Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Seagen
Biotech
BioMarin hires ex-Roche leader Hubbard as CCO—Chutes & Ladders
BioMarin names Hubbard as new CCO. Marett is retiring from BioNTech. GSK plucks Flagship partner as new SVP of research technologies.
Max Bayer
,
Gabrielle Masson
Mar 8, 2024 9:30am
Pfizer revamps oncology R&D strategy
Feb 29, 2024 6:03pm
Are DACs the new ADCs? Seagen pays Nurix $60M to find out
Sep 7, 2023 10:35am
Seagen puts $1.6B Merck-partnered ADC on the back burner
Aug 3, 2023 12:44pm
Pfizer shuffles R&D leadership to prepare for Seagen merger
Jul 27, 2023 9:05am
Abbvie's president adds COO title—Chutes & Ladders
Jun 30, 2023 9:30am